Patient Safety Orgs Cut Ties With Denham
Leapfrog's president and CEO, Leah Binder, said in an interview with HealthLeaders Media: "We've never taken any money from him and we have no contracts with him."
Leapfrog has asked Denham and his company, TMIT, to "remove any language from its website implying Leapfrog endorsement of 'test beds,' as this is not authorized. Further have TMIT remove any reference to a Leapfrog Hospital Survey 'flight simulator,' as this authorization was only given in 2006 and expired in 2007."
On Thursday, Binder issued a statement saying her board "was concerned with Dr. Denham's failure to reveal to the National Quality Forum or Leapfrog his potentially compromising relationship with CareFusion, which demonstrated a lack of transparency inconsistent with our organization's core values and mission."
Leapfrog also has "formally requested" that the "NQF perform a thorough scientific review of its full slate of endorsed safe practices," initiated an organization-wide update to its conflict of interest disclosures, even updating the latest update done last month.
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening